Cost Valuation

Cost Valuation: Concept Architecture

Orientation and learning roadmap

The page begins after resource use has been measured and asks which monetary value belongs on each unit. It then links perspective and data source to a unit cost, works through a treatment comparison, and explains how to align price years and discount future costs. The closing sections address non-market resources, double counting, and tests of decision sensitivity.

Keep quantities separate from monetary values

A costing exercise first identifies resources such as consultations, medicines, tests, staff hours, or hospital days. Valuation assigns a monetary amount to each measured unit under a stated perspective and decision purpose. A change in resource quantity and a change in the unit value have different explanations and should remain separately visible in the calculation.

For resource category $k$ in strategy $s$, let $q_{ks}$ be the quantity and $v_k$ the unit value in a common price year and currency. The simplest cost total is the sum of products across categories. A real analysis may require different unit values by strategy, place, time, or population and should represent those differences explicitly.

$$C_s=\sum_{k=1}^{K}q_{ks}v_k,\qquad\Delta C=C_{\mathrm{new}}-C_{\mathrm{comparator}}.$$

The equation is an accounting structure, not a guarantee that all categories are relevant or that every published unit cost fits the decision. Define the resource unit precisely: a “visit” may include tests and staff already costed elsewhere, while a drug's list price may differ from the amount actually paid. Specify what the chosen value includes before multiplying it by utilization.

Choose values for the stated perspective

A payer perspective asks which costs fall on that payer; a provider perspective may focus on resources consumed in delivering care; a societal perspective can include relevant patient time and other non-market resources. The same nurse hour or donated facility can have a different financial outlay and economic opportunity cost. A zero payment does not necessarily mean that the resource has no alternative use.

Use a unit value that matches the actual resource, location, period, and decision question. Sources may include procurement payments, national tariffs or reference costs, provider cost accounts, wage rates with relevant employment costs, and primary microcosting. Charges, reimbursements, and list prices are sometimes useful proxies but are not automatically equal to production cost or social opportunity cost.

NICE's reference-case cost scope and preferred sources apply to its evaluations; other health systems can have different perspectives and prices. A local budget analysis may need the contracted payment rather than a broad national average. State why a source fits the intended decision rather than treating a published figure as universally transferable.

Work through a transparent comparison

Suppose the new strategy uses six visits valued at 80 currency units each, two tests at 150 each, and medicines costing 200 per patient. Its cost is $6(80)+2(150)+200=980$ currency units. The comparator uses four visits, one test, and medicines costing 100, giving $4(80)+1(150)+100=570$ currency units.

The incremental cost is $980-570=410$ currency units per patient under these assumptions. The quantity differences are two visits, one test, and 100 currency units of medicine; their contributions are 160, 150, and 100, which sum to 410. This decomposition lets a reviewer see which inputs drive the estimate and replace any unit value without changing the underlying utilization record.

These figures are illustrative, not observed prices. The table assumes the visit value does not already include the listed tests or medicines. If it does, adding those lines would double count them, and the resource categories must be reconciled before the total can be used.

Align price year, currency, and timing

Costs drawn from different years should be expressed in a common price year before comparison using a suitable price index for the cost category and jurisdiction. For a unit value from source year $a$ moved to target year $b$, the mechanical adjustment is the index ratio. An index does not correct for a different service definition, negotiated price, or changed technology.

$$v_b=v_a\frac{I_b}{I_a},\qquad I_a>0.$$

For example, a source-year value of 80 with a relevant index of 100, updated to an index of 110, becomes $80(110/100)=88$ currency units in the target price year. The indices and values here are invented to show the arithmetic. Currency conversion, purchasing-power adjustment, and local price adaptation are distinct steps whose use depends on the comparison.

Future costs may also be discounted to a common time origin according to the applicable decision framework. In a constant-rate illustration with costs $C_t$ already expressed in the chosen real or nominal price basis, present value is $\sum_{t=0}^{T}C_t/(1+r)^t$ under a compatible discount rate $r$. Inflation adjustment changes the price-year basis; discounting changes how costs at different times are valued, so the two should not be confused or applied inconsistently.

Value resources that have no clear invoice

Patient travel, caregiver time, donated supplies, and capital use can matter even when the payer has no direct bill. Include them only when the stated perspective and decision require them, and disclose the method chosen. A non-market resource might be valued using replacement cost or the value of forgone activity, but different methods answer different questions and can give different results.

Long-lived equipment should be attributed over its useful service life and relevant volume rather than charging its whole purchase cost to one patient when others also use it. Capacity matters: the opportunity cost of an occupied theatre slot can differ when a queue displaces other care versus when truly idle time exists. Avoid assuming that a ledger entry or payment alone identifies the resource's incremental value.

Uncertain unit values warrant ranges or distributions that reflect the underlying evidence. A cost estimate with several precisely counted visits can still be uncertain because the visit definition, tariff, or future price is uncertain. Keep this valuation uncertainty distinct from uncertainty in how many visits the intervention causes.

Audit the cost build before using it

Check that each quantity has compatible units with its value and that the resource categories are mutually exclusive or explicitly adjusted for overlap. Reconcile patient-level totals to their components and, where applicable, aggregate totals to provider or payer accounts. Record the source, geography, year, adjustments, and included components for each important unit value.

For a spreadsheet, store Quantity, Unit Value, Price Year, and Source in separate columns and calculate each line as =Quantity*UnitValue. Test the 980, 570, and 410 totals in the example independently. Compare results under plausible alternative unit costs and cost perspectives when those choices could alter the conclusion.

An estimated cost is useful only for the decision it is constructed to inform. A tariff-based payer total may be suitable for one appraisal and unsuitable for measuring economic resources forgone in another. Present the costs alongside their quantities and valuation assumptions so readers can judge that fit.

Evidence used for this explanation

NICE guidance addresses resource use, unit costs, paid prices, and consistent cost treatment in its evaluation setting. The Global Health Cost Consortium reference case distinguishes financial and economic valuation and ties method choice to purpose. The numerical comparison and index adjustment are original calculations with explicitly illustrative values.

• NICE, NICE technology appraisal and highly specialised technologies guidance: the manual, economic evaluation.
• Global Health Cost Consortium, Reference Case for Estimating the Costs of Global Health Services and Interventions.
• Global Health Cost Consortium, “Estimating the cost of health interventions: an introduction”.
• Second Panel on Cost-Effectiveness in Health and Medicine, “Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses”. JAMA (2016).